经抗 VEGF 治疗 1 型新生血管性 AMD 过程中发生的全层黄斑孔行玻璃体切除术。
Vitrectomy for full thickness macular hole developed during the course of anti-VEGF treatment of type 1 neovascular AMD.
机构信息
Ophthalmic Clinic "Jasne Blonia," Lodz, Poland.
出版信息
Eur J Ophthalmol. 2022 Sep;32(5):NP5-NP8. doi: 10.1177/11206721211002123. Epub 2021 Mar 19.
PURPOSE
To report a case of treatment of a full-thickness macular hole, which appeared after 10 months of anti-VEGF treatment in neovascular age related macular degeneration (nAMD).
METHODS
The patient was diagnosed as type 1 nAMD. The coexisting vitreomacular traction caused a full thickness macular hole after 10 months of treatment.
PATIENTS
A 68-year-old woman treated with anti VEGF.
RESULTS
Vitrectomy with the temporal inverted ILM flap technique succeeded in closing the hole. Further anti-VEGF treatment followed.
CONCLUSION
FTMH is a rare complication or coexistence in nAMD. Vitrectomy and continuous anti-VEGF treatment might result in satisfactory anatomical and functional results.
目的
报告一例抗 VEGF 治疗后 10 个月出现全层黄斑裂孔的病例，该患者患有新生血管性年龄相关性黄斑变性（nAMD）。
方法
该患者被诊断为 1 型 nAMD。10 个月的治疗后，并存的玻璃黄斑牵引导致全层黄斑裂孔。
患者
一名接受抗 VEGF 治疗的 68 岁女性。
结果
采用颞侧倒置 ILM 瓣技术的玻璃体切除术成功封闭了裂孔。随后继续进行抗 VEGF 治疗。
结论
FTMH 是 nAMD 的罕见并发症或并存症。玻璃体切除术和持续的抗 VEGF 治疗可能会获得令人满意的解剖和功能结果。
Zotero 插件